TipRanks
CDT Equity (CDT)
NASDAQ:CDT
US Market

Compare CDT Equity (CDT) vs. Competitors

423 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
CDT Equity
$1.89
$1.11M
―
-100.00%
―
Moleculin Biotech
$0.61
$9.92M
-0.03
-96.11%
3 Buy
0 Hold
0 Sell
Strong Buy
Bone Biologics
$0.62
$1.31M
-0.26
-81.37%
―
Silexion Therapeutics
$0.36
$2.87M
>-0.01
-99.31%
0 Buy
1 Hold
0 Sell
Hold
Calidi Biotherapeutics
$1.31
$3.97M
-0.02
-95.67%
―
Azitra Inc
$0.18
$8.00M
-0.10
-82.09%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CDT
CDT Equity
0.99
-41,489.01
-100.00%
MBRX
Moleculin Biotech
0.49
-11.57
-95.97%
BBLG
Bone Biologics
0.48
-2.17
-82.01%
SLXN
Silexion Therapeutics
0.26
-38.44
-99.33%
CLDI
Calidi Biotherapeutics
1.08
-23.88
-95.67%
AZTR
Azitra Inc
0.13
-0.65
-83.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts